Promis Neurosciences Inc Stock Price - ARFXF

Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
Ultimate Trader (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Promis Neurosciences Inc ARFXF Other OTC Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.0057 -3.91% 0.14 0.15 0.14 0.149177 0.1457 14:34:07
Bid Price Ask Price Spread Spread % News
0.14 0.1497 0.0097 6.48% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
19 94,800 $ 0.147768 $ 14,008 128,513 0.1381 - 0.3356
Last Trade Time Type Quantity Stock Price Currency
14:34:07 1,500 $ 0.14 USD

Promis Neurosciences Inc Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 37.43M 261.41M $ -10.17M - -3.68 231.08M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
320.44k $ - 0.00% - -

more financials information »

Promis Neurosciences Inc News

Latest ARFXF Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ARFXF Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week0.177940.177940.140.1531259k-0.03794-21.32%
1 Month0.18070.1960.140.1665146k-0.0407-22.52%
3 Months0.201150.2180.140.1855130k-0.06115-30.40%
6 Months0.20950.33560.140.2135156k-0.0695-33.17%
1 Year0.28510.33560.13810.2130124k-0.1451-50.89%
3 Years0.11350.70.0750.2860142k0.026523.35%
5 Years0.3590.7030.01720.2707129k-0.219-61.00%

Promis Neurosciences Inc Description

ProMIS Neurosciences, Inc. is a development stage biotechnology company focused on discovering and developing antibody therapeutics selectively targeting toxic oligomers implicated in the development and progression of neurodegenerative diseases, in particular, Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and Parkinson's disease (PD). The Company's proprietary target discovery platform is based on the use of two complementary thermodynamic, computational discovery engines - ProMIS and Collective Coordinates - to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this unique precision approach, the Company is developing novel antibody therapeutics for AD, ALS and PD. ProMIS is headquartered in Toronto, Ontario, with offices in Cambridge, Massachusetts.

Your Recent History
Promis Neu..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.